Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2013-03-27 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
关于举行2012年年度报告网上说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about holding an online explanation meeting for the 2012 annual report. It mentions the date and time of the meeting and invites investors to participate. The document does not contain the annual report itself or detailed financial data, but rather it is a notice about a presentation related to the annual report. Given the short length (488 characters) and the nature of the content, this fits the category of an Investor Presentation (IP) or possibly an AGM Information (AGM-R). However, since it is specifically about an online explanation meeting for the annual report, which is a form of investor presentation, the best fit is Investor Presentation (IP).
2013-03-27 Chinese
董事会关于证券投资情况的专项说明
Regulatory Filings Classification · 95% confidence The document is a special statement from the board of directors regarding the company's securities investment situation for the year 2012. It details the securities held, investment activities, internal control execution, and includes opinions from the sponsor institution and independent directors. The document is relatively short (1136 characters) and focuses on disclosure of securities investment activities rather than presenting full financial statements or comprehensive financial performance. It is not an annual report, audit report, or earnings release. It is also not a regulatory filing or announcement of a report publication. The content fits best with a Regulatory Filings (RNS) category as it is a specific disclosure about securities investment activities without constituting a full financial report or other specialized filing type.
2013-03-27 Chinese
独立董事2012年度述职报告（刘建华）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2012. It details the director's attendance at board meetings, participation in committees, independent opinions on company matters, and involvement in the annual report preparation and audit process. The content focuses on governance and oversight activities rather than presenting financial statements or audit results themselves. The document is not a full Annual Report (10-K) or Audit Report (AR), but rather a management/governance-related report. It aligns best with Board/Management Information (MANG) as it relates to the activities and opinions of a board member. The document length is 2458 characters, which is relatively short and consistent with a report or statement by a board member rather than a full financial report. Therefore, the classification is MANG with high confidence.
2013-03-27 Chinese
内部控制鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制鉴证报告' which translates to 'Internal Control Assurance Report'. It references auditing standards and the evaluation of internal control effectiveness related to the financial statements as of December 31, 2012. The document is issued by a registered accounting firm and includes an assurance opinion on the effectiveness of internal controls. It is not a full annual report (10-K), nor is it a management discussion or earnings release. It is a standalone audit-related assurance report focusing on internal controls, which fits the definition of an Audit Report / Information (AR). The document length is short (1119 characters), but it contains substantive assurance content, not just an announcement or certification letter. Therefore, it should be classified as AR with high confidence. FY 2012
2013-03-27 Chinese
关于对公司控股股东及其他关联方占用资金情况的专项审计说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit report concerning the non-operating funds occupied by controlling shareholders and other related parties of 嘉事堂药业股份有限公司 for the year 2012. It includes an auditor's opinion, references to regulatory requirements by the China Securities Regulatory Commission, and detailed financial tables related to the audit scope. The document is titled as a "专项审计说明" (special audit explanation) and contains audit procedures, responsibilities, and conclusions. It is not a full annual report, nor a general audit report of financial statements, but a standalone audit report focused on a specific regulatory compliance issue. The document length is 2723 characters, which is sufficient for a detailed audit report but not a brief announcement. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2012
2013-03-27 Chinese
拟投资建设北京嘉事京西现代医药物流中心的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's planned investment to build a modern pharmaceutical logistics center. It includes details about the investment amount, project timeline, expected benefits, and risks. It references board approval but does not contain financial statements or detailed financial performance data. The document is relatively short (2070 characters) and serves as a formal announcement of a capital investment project rather than a full financial report or detailed management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2013-03-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.